Your browser doesn't support javascript.
loading
Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.
Cook, Theresa A; Jayamanne, Dasantha T; Wheeler, Helen R; Wong, Matthew H F; Parkinson, Jonathon F; Cook, Raymond J; Kastelan, Marina A; Cove, Nicola J; Brown, Christopher; Back, Michael F.
  • Cook TA; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.
  • Jayamanne DT; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Wheeler HR; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Wong MHF; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Parkinson JF; Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia.
  • Cook RJ; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Kastelan MA; The Brain Cancer Group, Sydney, New South Wales, Australia.
  • Cove NJ; Department of Neurosurgery, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Brown C; Department of Neurosurgery, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Back MF; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Neurooncol Pract ; 8(5): 601-608, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34594572
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article